CDC-801

DB15640InvestigationalSmall molecule

CDC-801 is under investigation in clinical trial NCT00006097 (Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia).

Chemical structure of CDC-801
Formula / weight
C23H24N2O5 · 408.454 g/mol (avg)
Code names
CC-1088 · CDC-801

Resolves to

Compound
UNII95HB56U8P8CAS192819-27-5ChEMBLCHEMBL88153
Structure
InChIKeyDDYUBCCTNHWSQM-UHFFFAOYSA-NSMILESCOC1=CC=C(C=C1OC1CCCC1)C(CC(N)=O)N1C(=O)C2=C(C=CC=C2)C1=O
Targets
P27815PDE4AQ08499PDE4DQ07343PDE4B

What you can answer from here — as of April 23, 2025

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with CDC-801, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In